Aarey Drugs Announces Book Closure for 36th AGM from Sep 24-30
Aarey Drugs & Pharmaceuticals Limited will close its books for the 36th AGM from September 24 to September 30, 2026. This is a routine procedural notice for the meeting.
This is a standard corporate compliance announcement related to the Annual General Meeting and does not directly impact the company's operations, financials, or stock price.
The announcement is a routine procedural notice regarding book closure for the Annual General Meeting and does not contain any new financial or business performance information.
Aarey Drugs & Pharmaceuticals Limited has announced the book closure period for its 36th Annual General Meeting (AGM). The registers of members and share transfer books will remain closed from Thursday, September 24, 2026, to Wednesday, September 30, 2026, inclusive. This closure is in accordance with Regulation 42 of the SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015.
What to do with a filing like this
Aarey Drugs & Pharmaceuticals Limited filed this with the NSE as a statutory disclosure, categorised under agm. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Aarey Drugs & Pharmaceuticals Limited. Read the original for the full detail.